What is Insulet's deferred costs?

Insulet (PODD) reported deferred costs of $25.4M in Q1 2026.

How has Insulet's deferred costs changed year-over-year?

Insulet's deferred costs increased by 18.7% year-over-year, from $21.4M to $25.4M.

What is the long-term trend for Insulet's deferred costs?

Over 5 years (2020 to 2025), Insulet's deferred costs has grown at a 18.1% compound annual growth rate (CAGR), from $11M to $25.3M.

Insulet PODD Deferred costs

Deferred costs at other companies

AssurantAIZ

$68.6M-14.2%

SamsaraIOT

$88.77M—

SBA CommunicationsSBAC

$3M+42.9%

F5, Inc.FFIV

$13.74M+65.4%

Nutanix, Inc.NTNX

$153.07M-4.2%

SalesforceCRM

$509M+39.5%

Other financials

Income statement

See full

Revenue$761.7M+33.9%

Gross profit$529.0M+29.3%

Operating income$122.1M+37.5%

Net income$91.1M+157%

EPS (diluted)$1.30+160%

Balance sheet

See full

Cash & equivalents$480.4M-62.6%

Total debt$969.7M-45.5%

Total equity$1.3B-2.1%

Total assets$3.0B-15.1%

Cash flow

See full

Operating cash flow$113.8M+78.4%

CapEx$24.3M+97.6%

Free cash flow$89.5M+73.8%

Valuation

See full

Market cap$10.1B-19.9%

Enterprise value$10.59B-19.4%

P/E33.3×+2.0×

P/S3.5×-2.3×

Profitability

See full

Gross margin71%+0.6pp

Operating margin17.5%+2.0pp

Net margin10.4%-7.9pp

FCF margin14.3%+1.1pp

Returns & leverage

See full

Return on equity23%-14.9pp

Debt / equity0.7×-0.6×

Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:CapitalizedContractCostNetCurrent.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's deferred costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insulet's deferred costs?: Insulet (PODD) reported deferred costs of $25.4M in Q1 2026.
How has Insulet's deferred costs changed year-over-year?: Insulet's deferred costs increased by 18.7% year-over-year, from $21.4M to $25.4M.
What is the long-term trend for Insulet's deferred costs?: Over 5 years (2020 to 2025), Insulet's deferred costs has grown at a 18.1% compound annual growth rate (CAGR), from $11M to $25.3M.